Armistice Capital’s Treace Medical Concepts TMCI Stock Holding History

Armistice Capital’s Portfolio TMCI Stock Details TMCI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$8.53M	Hold	6,364,000	–	–	0.15%	100
2025 Q4	$15.6M	Buy	6,364,000 +48,000	+0.8%	+$208K	0.19%	82
2025 Q3	$42.4M	Buy	6,316,000 +56,000	+0.9%	+$366K	0.63%	23
2025 Q2	$36.8M	Buy	6,260,000 +49,000	+0.8%	+$319K	0.64%	26
2025 Q1	$52.1M	Buy	6,211,000 +2,000	+0%	+$18K	0.78%	19
2024 Q4	$46.2M	Buy	6,209,000 +13,000	+0.2%	+$87K	0.63%	32
2024 Q3	$35.9M	Buy	6,196,000 +836,000	+16%	+$5.37M	0.57%	33
2024 Q2	$35.6M	Buy	5,360,000 +2,960,000	+123%	+$23.9M	0.45%	37
2024 Q1	$31.3M	Sell	2,400,000 -456,000	-16%	-$6.08M	0.42%	38
2023 Q4	$36.4M	Buy	+2,856,000	New	+$28.9M	0.5%	35

Other funds holding TMCI

Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CBU

CIBC Bancorp USA Chicago, Illinois $74.4B AUM

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Armistice Capital's TMCI Position: Q1 2026 in Review

Armistice Capital held its Treace Medical Concepts (TMCI) position steady in Q1 2026 at 6,364,000 shares worth $8.53M. The position accounts for 0.15% of the portfolio, ranked #100.

Armistice Capital first reported a position in TMCI in Q4 2023 and has held it in 10 quarters since. The position peaked at $52.1M in Q1 2025. 118 funds tracked by Wall St. Rank hold TMCI as of Q1 2026.

Armistice Capital held 6,364,000 shares of Treace Medical Concepts worth $8.53M as of Q1 2026.
Armistice Capital left its Treace Medical Concepts share count unchanged in Q1 2026.
Treace Medical Concepts made up 0.15% of Armistice Capital's portfolio in Q1 2026, its #100 holding.
Armistice Capital first reported a position in Treace Medical Concepts in Q4 2023 and has held it in 10 quarters since.
Armistice Capital's Treace Medical Concepts position peaked at $52.1M in Q1 2025.
118 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q1 2026.

Based on Armistice Capital's 13F filing for Q1 2026, filed 15 May 2026.